Antihyperglycemic Effect of Ginkgo biloba Extract in Streptozotocin-Induced Diabetes in Rats

Table 1

Changes of the body weight (g) of rats in the seven groups during the experimental period of 30 days.

	Before treatment	48 h	15 days	30 days
N group	178.3 ± 5.6	183.4 ± 6.5	214.3 ± 7.7	220.3 ± 6.3
D group	180.1 ± 6.9	177.3 ± 5.9	174.1 ± 10.2^a	169.3 ± 11.6^a
N + G group	176.9 ± 5.8	186.1 ± 8.8	209.6 ± 9.6^b	220.8 ± 10.0^b
N + LG group	179.3 ± 7.6	183.0 ± 7.2	187.6 ± 5.5^a,b	206.3 ± 5.9^a,b
N + MG group	177.4 ± 5.1	180.6 ± 4.6	190.6 ± 4.9^a,b	213.6 ± 9.9^b
N + HG group	178.6 ± 7.7	186.9 ± 5.8	199.5 ± 7.1^a,b	216.2 ± 7.8^b
N + GLI group	180.2 ± 6.3	187.9 ± 5.0	196.3 ± 6.1^a,b	212.1 ± 11.8^b

Values are means ± SD for 10 rats in each group. N group: normal control; D group: diabetes group; N + G group: normal control plus GBE; D + LG group: diabetes plus low GBE treatment; D + MG group: diabetes plus middle GBE treatment; D + HG group: diabetes plus high GBE treatment; D + GLI group: diabetes plus glibenclamide treatment.
^aIndicates statistical significance of 𝑃<0.01 compared to N group; ^b𝑃<0.01 compared to D group.